85 SUPERIOR LONG-TERM OUTCOMES OF ALLOGENEIC HCT IN RESPONSE COMPARED TO RELAPSED OR REFRACTORY AFTER HMA FOR PATIENTS WITH LOWER RISK MDS

Authors :: Yang Soo Kim
Hyeoung-Joon Kim
Jae-Sook Ahn
Young Rok Do
Ho Jin Shin
Hyung-Ryong Kim
Ho-Sup Lee
Young Don Joo
Sang-Kyun Sohn
Sung Hwa Bae
Y.Y. Cho
Joon Ho Moon
Sangmin Lee
Moo-Kon Song
Won Sik Lee
Source :: Leukemia Research. 39:S41-S42
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Refractory
business.industry
Internal medicine
Long term outcomes
Medicine
Allogeneic hct
Hematology
business
Lower risk

Tools